NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NBIX is currently covered by 24 analysts with an average price target of $121.22. This is a potential upside of $25.94 (27.23%) from yesterday's end of day stock price of $95.28.

Neurocrine Biosciences's activity chart (see below) currently has 310 price targets and 297 ratings on display. The stock rating distribution of NBIX is 27.62% HOLD and 72.38% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.25% with an average time for these price targets to be met of 268.32 days.

Highest price target for NBIX is $219, Lowest price target is $114, average price target is $160.61.

Most recent stock forecast was given by ASHWANI VERMA from UBS on 04-Apr-2025.

Currently out of the existing stock ratings of NBIX, 29 are a HOLD (27.62%), 76 are a BUY (72.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$137

$41.35 (43.23%)

$162

5 days ago
(04-Apr-2025)

3/6 (50%)

$41.35 (43.23%)

262

Buy

$184

$88.35 (92.37%)

$181

14 days ago
(26-Mar-2025)

15/18 (83.33%)

$69.55 (60.77%)

332

Buy

$150

$54.35 (56.82%)

$185

1 months 2 days ago
(07-Mar-2025)

7/11 (63.64%)

$37.34 (33.14%)

453

Buy

$185

$89.35 (93.41%)

$185

1 months 16 days ago
(24-Feb-2025)

13/22 (59.09%)

$65.89 (55.32%)

528

Buy

$163

$67.35 (70.41%)

$180

1 months 30 days ago
(10-Feb-2025)

1/4 (25%)

$44.19 (37.19%)

43

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 268.32 days on average for the stock forecasts to be realized with a an average price target met ratio 80.25

Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Danielle Brill works at RAYMOND JAMES and has 7 price targets and 7 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Jay Olson with highest potential upside - $123.35

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Thomas Wei with lowest potential downside - -$69.25

Neurocrine Biosciences in the News

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals.

Enable social media cookies to share NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals. By Mill Chart Last update: Apr 9, 2025 Uncover the potential of NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) as our stock screener’s choice for an undervalued stock. NBIX maintains a strong financial position and offers an appealing valuation. We’ll delve...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?